GleanMark

REVIXFLU Trademark

REVIXFLU is a USPTO trademark filed by GlaxoSmithKline Biologicals SA. Status: Registered.

Trademark Facts

MarkREVIXFLU
Serial Number98896129
Registration Number8082807
StatusRegistered
Filing Date2024-12-11
Registration Date2025-12-30
Mark TypeWord
Nice Classes005 (Pharmaceuticals)
OwnerGlaxoSmithKline Biologicals SA
Attorney of RecordElizabeth K. Rucki
Prosecution Events21
Latest EventNRCC on 2025-12-30

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Recent Prosecution Activity

DateCodeTypeDescription
2025-12-30NRCCENOTICE OF REGISTRATION CONFIRMATION EMAILED
2025-12-30R.PRAREGISTERED-PRINCIPAL REGISTER
2025-11-11NPUBEOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2025-11-11PUBOAPUBLISHED FOR OPPOSITION
2025-11-05NONPENOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2025-10-16PBCRZWITHDRAWN FROM PUB - OG REVIEW QUERY
2025-10-15NONPENOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2025-09-19CNSAOAPPROVED FOR PUB - PRINCIPAL REGISTER
2025-09-18TEMEITEAS/EMAIL CORRESPONDENCE ENTERED
2025-09-18CRFAICORRESPONDENCE RECEIVED IN LAW OFFICE

Other Trademarks from GlaxoSmithKline Biologicals SA

GlaxoSmithKline Biologicals SA owns 5 USPTO trademarks (5 live).

View full portfolio →

Nice Class Context

Related